Israel - English - Ministry of Health

novartis israel ltd - fentanyl - patches - fentanyl 2.1 mg/patch - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

novartis israel ltd - fentanyl - patches - fentanyl 4.2 mg/patch - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

novartis israel ltd - fentanyl - patches - fentanyl 8.4 mg/patch - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

novartis israel ltd - fentanyl - patches - fentanyl 12.6 mg/patch - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

megapharm ltd - aldesleukin - powder for solution for infusion - aldesleukin 18 miu - aldesleukin - proleukin (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic rcc). proleukin is indicated for the treatment of adults with metastatic melanoma.careful patient selection is mandatory prior to the administration of proleukin.

Israel - English - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - solution (oral) - fluoxetine as hydrochloride 4 mg/ml - fluoxetine - adults:major depressive episodes.obsessive-compulsive disorder (ocd).bulimia nervosa: fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.children and adolescents aged 8 years and above:moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.8 ng 100 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.2 - 0.4 ng 50 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorders . narcolepsy.

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .